Progression-directed ablative radiotherapy improves event-free survival in oligoprogressive NSCLC.

Front Oncol · 2026 · PMC13243050 · PMID 42266655

Europe PMC DOI

hedged sentence

0.0900

closest p · 1.8× alpha

0.0900

boldest claim

The sentences

showed a trendp = 0.09so close (0.05 < p ≤ 0.1)

did not reach statistical significanceno p-value reported

Patients achieving CR before oligoprogression showed a trend toward improved prognosis (HR = 0.41, 95% CI: 0.14–1.18; p = 0.09), although this did not reach statistical significance.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.